JPRN-UMIN000005292
Recruiting
未知
Study on risk reducing salpingo-oophorectomy(RRSO) for BRCA1/2 mutation carriers - Study on RRSO for BRCA1/2 mutation carriers
Cancer Institute Hospital Department of Gynecology, Breast center, Clinical Genetic Oncology0 sites200 target enrollmentApril 1, 2011
Conditionshereditary breast and ovarian cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- hereditary breast and ovarian cancer
- Sponsor
- Cancer Institute Hospital Department of Gynecology, Breast center, Clinical Genetic Oncology
- Enrollment
- 200
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.She desires having babies. 2\.The case in which IRB doesn't approve to perform PBSO.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Evaluation of risk-reducing salpingo-oophorectomy for patients with BRCA 1/2 mutatiohereditary breast and ovarian cancer: HBOCJPRN-UMIN000023606Kindai University Hospital
Recruiting
Not Applicable
Clinical study of risk reducing salpingo-oophorectomy (RRSO) in patients with pathological variants of the BRCA1/2 geneHereditary Breast and Ovarian Cancer, HBOCJPRN-UMIN000042914Sapporo Medical University20
Recruiting
Not Applicable
Establishment of risk-reducing salpingo-oohorectomy for hereditary breast and ovarian syndromeovarian cancer tubal cancerJPRN-UMIN000024515Fujita Health University, Gynecology and Obstetrics5
Completed
Not Applicable
Risk reducing salpingo-oophorectomy RRSO in BRCA1/2 mutation carriers.Hereditary Breast and Ovarian CancerJPRN-UMIN000027999agoya university faculty of Medicine8
Recruiting
Not Applicable
Study on risk reducing bilateral salpingo-oophorectomy (RRSO) for BRCA1/2 mutation carriershereditary breast and ovarian cancerJPRN-UMIN000018302The Jikei university, school of medicine5